NANOVIRICIDES

NanoViricides is a company developing nano-medicine therapeutics technologies to fight viral diseases. The company was founded by Anil R. Diwan in 2005 in West Haven, Connecticut, United States.

The company looks to discover, develop, and commercialize therapeutics in order to advance the care of patients that are dealing with dangerous viral infections. The company has developed an agent known as a nanoviricide, which is designed to trick a virus into attaching it to itself which will, in turn, kill the virus. Once attached, the nanoviricide wraps around the virus and traps it, causing it to lose its coat proteins, neutralizing the virus entirely.

COVID-19

With the outbreak of COVID-19 (coronavirus), the company has began working on a treatment for the novel coronavirus since January 30, 2020. The company has completed the synthesis of a several nanoviricide drug candidates for testing after the identification of the virus binding ligands. The company has tested against two low-threat circulating coronaviruses and has expanded them to enable testing of drug candidates.